Pulike Biological Engineering, Inc. (SHA:603566)

Market Cap	4.87B
Revenue (ttm)	1.12B
Net Income (ttm)	135.04M
Shares Out	341.92M
EPS (ttm)	0.40
PE Ratio	35.70
Forward PE	25.43
Dividend	0.40 (2.84%)
Ex-Dividend Date	Oct 17, 2025

Volume	3,500,426
Average Volume	4,161,739
Open	14.10
Previous Close	14.09
Day's Range	13.98 - 14.30
52-Week Range	11.28 - 15.79
Beta	0.29
RSI	47.72
Earnings Date	Oct 24, 2025

About SHA:603566

Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 1,551
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603566

Financial Performance

In 2024, SHA:603566's revenue was 1.04 billion, a decrease of -16.77% compared to the previous year's 1.25 billion. Earnings were 92.81 million, a decrease of -46.82%.